Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial Article Swipe
Roberto A. Leon‐Ferre
,
Katrina Dimitroff
,
Christina Yau
,
K. Giridhar
,
Rita Mukhtar
,
Gillian L. Hirst
,
Nola M. Hylton
,
Jane Perlmutter
,
Angela DeMichele
,
Douglas Yee
,
Laura van ’t Veer
,
Hope Rugo
,
W. Fraser Symmans
,
M. P. Goetz
,
Laura J. Esserman
,
JC Boughey
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s13058-025-02070-1
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s13058-025-02070-1
I-SPY 2 TRIAL beginning December 31, 2009: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY 2), NCT01042379.
Related Topics
Concepts
Medicine
Surgical oncology
Breast cancer
Oncology
Internal medicine
Stage (stratigraphy)
Neoadjuvant therapy
Triple-negative breast cancer
Systemic therapy
Randomized controlled trial
Clinical trial
Cancer
Paleontology
Biology
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s13058-025-02070-1
- https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-02070-1
- OA Status
- gold
- Cited By
- 2
- References
- 22
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411535820
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411535820Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s13058-025-02070-1Digital Object Identifier
- Title
-
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trialWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-23Full publication date if available
- Authors
-
Roberto A. Leon‐Ferre, Katrina Dimitroff, Christina Yau, K. Giridhar, Rita Mukhtar, Gillian L. Hirst, Nola M. Hylton, Jane Perlmutter, Angela DeMichele, Douglas Yee, Laura van ’t Veer, Hope Rugo, W. Fraser Symmans, M. P. Goetz, Laura J. Esserman, JC BougheyList of authors in order
- Landing page
-
https://doi.org/10.1186/s13058-025-02070-1Publisher landing page
- PDF URL
-
https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-02070-1Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-02070-1Direct OA link when available
- Concepts
-
Medicine, Surgical oncology, Breast cancer, Oncology, Internal medicine, Stage (stratigraphy), Neoadjuvant therapy, Triple-negative breast cancer, Systemic therapy, Randomized controlled trial, Clinical trial, Cancer, Paleontology, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2Per-year citation counts (last 5 years)
- References (count)
-
22Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411535820 |
|---|---|
| doi | https://doi.org/10.1186/s13058-025-02070-1 |
| ids.doi | https://doi.org/10.1186/s13058-025-02070-1 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40551254 |
| ids.openalex | https://openalex.org/W4411535820 |
| fwci | 7.09350384 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D005260 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Female |
| mesh[2].qualifier_ui | Q000473 |
| mesh[2].descriptor_ui | D064726 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | pathology |
| mesh[2].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[3].qualifier_ui | Q000401 |
| mesh[3].descriptor_ui | D064726 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | mortality |
| mesh[3].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[4].qualifier_ui | Q000188 |
| mesh[4].descriptor_ui | D064726 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | drug therapy |
| mesh[4].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[5].qualifier_ui | Q000628 |
| mesh[5].descriptor_ui | D064726 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | therapy |
| mesh[5].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D020360 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Neoadjuvant Therapy |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D018719 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Receptor, ErbB-2 |
| mesh[8].qualifier_ui | Q000473 |
| mesh[8].descriptor_ui | D018365 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | pathology |
| mesh[8].descriptor_name | Neoplasm, Residual |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008875 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Middle Aged |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D011379 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Prognosis |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D009367 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Neoplasm Staging |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000328 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Adult |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000368 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Aged |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D000971 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D047368 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Tumor Burden |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D016896 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Treatment Outcome |
| mesh[17].qualifier_ui | Q000473 |
| mesh[17].descriptor_ui | D009364 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | pathology |
| mesh[17].descriptor_name | Neoplasm Recurrence, Local |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D005260 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Female |
| mesh[20].qualifier_ui | Q000473 |
| mesh[20].descriptor_ui | D064726 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | pathology |
| mesh[20].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[21].qualifier_ui | Q000401 |
| mesh[21].descriptor_ui | D064726 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | mortality |
| mesh[21].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[22].qualifier_ui | Q000188 |
| mesh[22].descriptor_ui | D064726 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | drug therapy |
| mesh[22].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[23].qualifier_ui | Q000628 |
| mesh[23].descriptor_ui | D064726 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | therapy |
| mesh[23].descriptor_name | Triple Negative Breast Neoplasms |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D020360 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Neoadjuvant Therapy |
| mesh[25].qualifier_ui | Q000378 |
| mesh[25].descriptor_ui | D018719 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | metabolism |
| mesh[25].descriptor_name | Receptor, ErbB-2 |
| mesh[26].qualifier_ui | Q000473 |
| mesh[26].descriptor_ui | D018365 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | pathology |
| mesh[26].descriptor_name | Neoplasm, Residual |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008875 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Middle Aged |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D011379 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Prognosis |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D009367 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Neoplasm Staging |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000328 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Adult |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000368 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D000971 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D047368 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Tumor Burden |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D016896 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Treatment Outcome |
| mesh[35].qualifier_ui | Q000473 |
| mesh[35].descriptor_ui | D009364 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | pathology |
| mesh[35].descriptor_name | Neoplasm Recurrence, Local |
| type | article |
| title | Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial |
| biblio.issue | 1 |
| biblio.volume | 27 |
| biblio.last_page | 115 |
| biblio.first_page | 115 |
| grants[0].funder | https://openalex.org/F4320306080 |
| grants[0].award_id | |
| grants[0].funder_display_name | Foundation for the National Institutes of Health |
| grants[1].funder | https://openalex.org/F4320306260 |
| grants[1].award_id | |
| grants[1].funder_display_name | Breast Cancer Research Foundation |
| topics[0].id | https://openalex.org/T10183 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Breast Cancer Treatment Studies |
| topics[1].id | https://openalex.org/T10755 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9991999864578247 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | HER2/EGFR in Cancer Research |
| topics[2].id | https://openalex.org/T11752 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9990000128746033 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Treatment and Pharmacology |
| funders[0].id | https://openalex.org/F4320306080 |
| funders[0].ror | https://ror.org/00k86s890 |
| funders[0].display_name | Foundation for the National Institutes of Health |
| funders[1].id | https://openalex.org/F4320306260 |
| funders[1].ror | https://ror.org/0348ff195 |
| funders[1].display_name | Breast Cancer Research Foundation |
| is_xpac | False |
| apc_list.value | 2380 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2919 |
| apc_paid.value | 2380 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2919 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8536527156829834 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780140570 |
| concepts[1].level | 2 |
| concepts[1].score | 0.832719087600708 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q3545481 |
| concepts[1].display_name | Surgical oncology |
| concepts[2].id | https://openalex.org/C530470458 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7687543630599976 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[2].display_name | Breast cancer |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.7006649971008301 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.6213342547416687 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C146357865 |
| concepts[5].level | 2 |
| concepts[5].score | 0.6098284721374512 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[5].display_name | Stage (stratigraphy) |
| concepts[6].id | https://openalex.org/C2778292576 |
| concepts[6].level | 4 |
| concepts[6].score | 0.5682950615882874 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q6991934 |
| concepts[6].display_name | Neoadjuvant therapy |
| concepts[7].id | https://openalex.org/C2780110267 |
| concepts[7].level | 4 |
| concepts[7].score | 0.5663565397262573 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7843332 |
| concepts[7].display_name | Triple-negative breast cancer |
| concepts[8].id | https://openalex.org/C185926286 |
| concepts[8].level | 4 |
| concepts[8].score | 0.5545660853385925 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1929812 |
| concepts[8].display_name | Systemic therapy |
| concepts[9].id | https://openalex.org/C168563851 |
| concepts[9].level | 2 |
| concepts[9].score | 0.5518197417259216 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[9].display_name | Randomized controlled trial |
| concepts[10].id | https://openalex.org/C535046627 |
| concepts[10].level | 2 |
| concepts[10].score | 0.5161081552505493 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[10].display_name | Clinical trial |
| concepts[11].id | https://openalex.org/C121608353 |
| concepts[11].level | 2 |
| concepts[11].score | 0.43349894881248474 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[11].display_name | Cancer |
| concepts[12].id | https://openalex.org/C151730666 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[12].display_name | Paleontology |
| concepts[13].id | https://openalex.org/C86803240 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[13].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8536527156829834 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/surgical-oncology |
| keywords[1].score | 0.832719087600708 |
| keywords[1].display_name | Surgical oncology |
| keywords[2].id | https://openalex.org/keywords/breast-cancer |
| keywords[2].score | 0.7687543630599976 |
| keywords[2].display_name | Breast cancer |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.7006649971008301 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.6213342547416687 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/stage |
| keywords[5].score | 0.6098284721374512 |
| keywords[5].display_name | Stage (stratigraphy) |
| keywords[6].id | https://openalex.org/keywords/neoadjuvant-therapy |
| keywords[6].score | 0.5682950615882874 |
| keywords[6].display_name | Neoadjuvant therapy |
| keywords[7].id | https://openalex.org/keywords/triple-negative-breast-cancer |
| keywords[7].score | 0.5663565397262573 |
| keywords[7].display_name | Triple-negative breast cancer |
| keywords[8].id | https://openalex.org/keywords/systemic-therapy |
| keywords[8].score | 0.5545660853385925 |
| keywords[8].display_name | Systemic therapy |
| keywords[9].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[9].score | 0.5518197417259216 |
| keywords[9].display_name | Randomized controlled trial |
| keywords[10].id | https://openalex.org/keywords/clinical-trial |
| keywords[10].score | 0.5161081552505493 |
| keywords[10].display_name | Clinical trial |
| keywords[11].id | https://openalex.org/keywords/cancer |
| keywords[11].score | 0.43349894881248474 |
| keywords[11].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1186/s13058-025-02070-1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S42140187 |
| locations[0].source.issn | 1465-5411, 1465-542X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1465-5411 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Breast Cancer Research |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-02070-1 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Breast Cancer Research |
| locations[0].landing_page_url | https://doi.org/10.1186/s13058-025-02070-1 |
| locations[1].id | pmid:40551254 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Breast cancer research : BCR |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40551254 |
| locations[2].id | pmh:oai:europepmc.org:10993782 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12183850 |
| locations[3].id | pmh:oai:doaj.org/article:743d02c7e42542bda69f2f64c1391b27 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Breast Cancer Research, Vol 27, Iss 1, Pp 1-12 (2025) |
| locations[3].landing_page_url | https://doaj.org/article/743d02c7e42542bda69f2f64c1391b27 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5069569795 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0594-4441 |
| authorships[0].author.display_name | Roberto A. Leon‐Ferre |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1330342723, https://openalex.org/I2802423016 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. [email protected]. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210125099 |
| authorships[0].affiliations[1].raw_affiliation_string | Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I1330342723 |
| authorships[0].institutions[0].ror | https://ror.org/02qp3tb03 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I1330342723 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Mayo Clinic |
| authorships[0].institutions[1].id | https://openalex.org/I4210125099 |
| authorships[0].institutions[1].ror | https://ror.org/03jp40720 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I1330342723, https://openalex.org/I4210125099 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | Mayo Clinic in Arizona |
| authorships[0].institutions[2].id | https://openalex.org/I2802423016 |
| authorships[0].institutions[2].ror | https://ror.org/02s47w807 |
| authorships[0].institutions[2].type | nonprofit |
| authorships[0].institutions[2].lineage | https://openalex.org/I2802423016 |
| authorships[0].institutions[2].country_code | US |
| authorships[0].institutions[2].display_name | WinnMed |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Roberto A Leon-Ferre |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. [email protected]., Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. [email protected]. |
| authorships[1].author.id | https://openalex.org/A5098924194 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Katrina Dimitroff |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[1].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[1].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[1].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[1].institutions[1].id | https://openalex.org/I180670191 |
| authorships[1].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | University of California, San Francisco |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | K Dimitroff |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[2].author.id | https://openalex.org/A5062190609 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1937-0859 |
| authorships[2].author.display_name | Christina Yau |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[2].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[2].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[2].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[2].institutions[1].id | https://openalex.org/I180670191 |
| authorships[2].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | University of California, San Francisco |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | C Yau |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[3].author.id | https://openalex.org/A5006814132 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4242-6363 |
| authorships[3].author.display_name | K. Giridhar |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1330342723 |
| authorships[3].affiliations[0].raw_affiliation_string | Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. |
| authorships[3].institutions[0].id | https://openalex.org/I1330342723 |
| authorships[3].institutions[0].ror | https://ror.org/02qp3tb03 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1330342723 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Mayo Clinic |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | K V Giridhar |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. |
| authorships[4].author.id | https://openalex.org/A5112435598 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Rita Mukhtar |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[4].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[4].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[4].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[4].institutions[1].id | https://openalex.org/I180670191 |
| authorships[4].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | University of California, San Francisco |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | R Mukhtar |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[5].author.id | https://openalex.org/A5076178845 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4502-0035 |
| authorships[5].author.display_name | Gillian L. Hirst |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[5].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[5].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[5].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[5].institutions[1].id | https://openalex.org/I180670191 |
| authorships[5].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | University of California, San Francisco |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | G Hirst |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[6].author.id | https://openalex.org/A5034796205 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6747-1662 |
| authorships[6].author.display_name | Nola M. Hylton |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[6].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[6].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[6].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[6].institutions[1].id | https://openalex.org/I180670191 |
| authorships[6].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | University of California, San Francisco |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | N Hylton |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[7].author.id | https://openalex.org/A5071749616 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-5008-0406 |
| authorships[7].author.display_name | Jane Perlmutter |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210155281 |
| authorships[7].affiliations[0].raw_affiliation_string | Gemini Group, Ann Arbor, Michigan, USA. |
| authorships[7].institutions[0].id | https://openalex.org/I4210155281 |
| authorships[7].institutions[0].ror | https://ror.org/058646248 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210155281 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Gemini Computers (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | J Perlmutter |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Gemini Group, Ann Arbor, Michigan, USA. |
| authorships[8].author.id | https://openalex.org/A5005537242 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-1297-4251 |
| authorships[8].author.display_name | Angela DeMichele |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I79576946 |
| authorships[8].affiliations[0].raw_affiliation_string | University of Pennsylvania, Philadelphia, PA, USA. |
| authorships[8].institutions[0].id | https://openalex.org/I79576946 |
| authorships[8].institutions[0].ror | https://ror.org/00b30xv10 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I79576946 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | University of Pennsylvania |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | A DeMichele |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | University of Pennsylvania, Philadelphia, PA, USA. |
| authorships[9].author.id | https://openalex.org/A5033966004 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3387-4009 |
| authorships[9].author.display_name | Douglas Yee |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I130238516 |
| authorships[9].affiliations[0].raw_affiliation_string | University of Minnesota, Minneapolis, MN, USA. |
| authorships[9].institutions[0].id | https://openalex.org/I130238516 |
| authorships[9].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | University of Minnesota |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | D Yee |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | University of Minnesota, Minneapolis, MN, USA. |
| authorships[10].author.id | https://openalex.org/A5014135109 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-9838-8298 |
| authorships[10].author.display_name | Laura van ’t Veer |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[10].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[10].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[10].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[10].institutions[0].type | facility |
| authorships[10].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[10].institutions[1].id | https://openalex.org/I180670191 |
| authorships[10].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[10].institutions[1].country_code | US |
| authorships[10].institutions[1].display_name | University of California, San Francisco |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | L van 't Veer |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[11].author.id | https://openalex.org/A5002767668 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Hope Rugo |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[11].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[11].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[11].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[11].institutions[0].type | facility |
| authorships[11].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[11].institutions[1].id | https://openalex.org/I180670191 |
| authorships[11].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[11].institutions[1].type | education |
| authorships[11].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[11].institutions[1].country_code | US |
| authorships[11].institutions[1].display_name | University of California, San Francisco |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | H Rugo |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[12].author.id | https://openalex.org/A5001315712 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-1526-184X |
| authorships[12].author.display_name | W. Fraser Symmans |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1343551460 |
| authorships[12].affiliations[0].raw_affiliation_string | University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| authorships[12].institutions[0].id | https://openalex.org/I1343551460 |
| authorships[12].institutions[0].ror | https://ror.org/04twxam07 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I1343551460 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | The University of Texas MD Anderson Cancer Center |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | W F Symmans |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| authorships[13].author.id | https://openalex.org/A5069665093 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | M. P. Goetz |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I1330342723 |
| authorships[13].affiliations[0].raw_affiliation_string | Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. |
| authorships[13].institutions[0].id | https://openalex.org/I1330342723 |
| authorships[13].institutions[0].ror | https://ror.org/02qp3tb03 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I1330342723 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Mayo Clinic |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | M P Goetz |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. |
| authorships[14].author.id | https://openalex.org/A5072789687 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9202-4568 |
| authorships[14].author.display_name | Laura J. Esserman |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I180670191, https://openalex.org/I4210167126 |
| authorships[14].affiliations[0].raw_affiliation_string | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[14].institutions[0].id | https://openalex.org/I4210167126 |
| authorships[14].institutions[0].ror | https://ror.org/05yndxy10 |
| authorships[14].institutions[0].type | facility |
| authorships[14].institutions[0].lineage | https://openalex.org/I180670191, https://openalex.org/I4210110664, https://openalex.org/I4210167126 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | UCSF Helen Diller Family Comprehensive Cancer Center |
| authorships[14].institutions[1].id | https://openalex.org/I180670191 |
| authorships[14].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[14].institutions[1].type | education |
| authorships[14].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[14].institutions[1].country_code | US |
| authorships[14].institutions[1].display_name | University of California, San Francisco |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | L Esserman |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. |
| authorships[15].author.id | https://openalex.org/A5023781047 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | JC Boughey |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1330342723 |
| authorships[15].affiliations[0].raw_affiliation_string | Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. |
| authorships[15].institutions[0].id | https://openalex.org/I1330342723 |
| authorships[15].institutions[0].ror | https://ror.org/02qp3tb03 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I1330342723 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Mayo Clinic |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | J C Boughey |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-02070-1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10183 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Breast Cancer Treatment Studies |
| related_works | https://openalex.org/W4407484668, https://openalex.org/W4200237862, https://openalex.org/W2941613202, https://openalex.org/W4402477283, https://openalex.org/W2948806433, https://openalex.org/W4206709538, https://openalex.org/W1991531502, https://openalex.org/W2606809989, https://openalex.org/W4200385978, https://openalex.org/W4410498276 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1186/s13058-025-02070-1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S42140187 |
| best_oa_location.source.issn | 1465-5411, 1465-542X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1465-5411 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Breast Cancer Research |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-02070-1 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Breast Cancer Research |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s13058-025-02070-1 |
| primary_location.id | doi:10.1186/s13058-025-02070-1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S42140187 |
| primary_location.source.issn | 1465-5411, 1465-542X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1465-5411 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Breast Cancer Research |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/s13058-025-02070-1 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Breast Cancer Research |
| primary_location.landing_page_url | https://doi.org/10.1186/s13058-025-02070-1 |
| publication_date | 2025-06-23 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3122861570, https://openalex.org/W4400800926, https://openalex.org/W4389681263, https://openalex.org/W2618058692, https://openalex.org/W2902218997, https://openalex.org/W3165576985, https://openalex.org/W2585697071, https://openalex.org/W4200028620, https://openalex.org/W3199819343, https://openalex.org/W2803973904, https://openalex.org/W4362705930, https://openalex.org/W4366368294, https://openalex.org/W4399624033, https://openalex.org/W4399883125, https://openalex.org/W2471493685, https://openalex.org/W2474664935, https://openalex.org/W3162334759, https://openalex.org/W2301046115, https://openalex.org/W3130191307, https://openalex.org/W2075894019, https://openalex.org/W3006134372, https://openalex.org/W4200350191 |
| referenced_works_count | 22 |
| abstract_inverted_index.2 | 1 |
| abstract_inverted_index.to | 13 |
| abstract_inverted_index.2), | 18 |
| abstract_inverted_index.31, | 5 |
| abstract_inverted_index.and | 8 |
| abstract_inverted_index.2009: | 6 |
| abstract_inverted_index.I-SPY | 0 |
| abstract_inverted_index.Novel | 11 |
| abstract_inverted_index.TRIAL | 2 |
| abstract_inverted_index.Treat | 14 |
| abstract_inverted_index.(I-SPY | 17 |
| abstract_inverted_index.Agents | 12 |
| abstract_inverted_index.Breast | 15 |
| abstract_inverted_index.Cancer | 16 |
| abstract_inverted_index.Adaptive | 10 |
| abstract_inverted_index.December | 4 |
| abstract_inverted_index.beginning | 3 |
| abstract_inverted_index.Neoadjuvant | 7 |
| abstract_inverted_index.NCT01042379. | 19 |
| abstract_inverted_index.Personalized | 9 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 95 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 16 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.550000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.93468899 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |